British Pharmaceutical Codex
British Pharmaceutical Codex (BPC) was a book published by the Pharmaceutical Society of Great Britain until 1973. It provided standards for the identity and purity of substances used in medicine and pharmacy in the United Kingdom.
History[edit]
The first edition of the BPC was published in 1907, replacing the unofficial Pharmacopoeia of the Pharmaceutical Society. The BPC was intended to be a national standard for the UK, similar to the United States Pharmacopeia and the Pharmacopoeia of India. The BPC included not only drugs and preparations that were in the British Pharmacopoeia (BP), but also additional drugs and preparations that were commonly used in the UK but not included in the BP.
Content[edit]
The BPC contained monographs for drugs and preparations, with information on their description, identification, assay, impurities, and storage. It also included general notices, general methods of analysis, and appendices on reagents and solutions, buffers, and standard solutions. The BPC also provided information on the therapeutic uses and side effects of the drugs, which was not included in the BP.
Relevance[edit]
The BPC was a valuable resource for pharmacists and other healthcare professionals. It provided a comprehensive and authoritative source of information on the identity and purity of drugs and preparations used in the UK. The BPC was also used as a reference in legal cases involving drugs and medicines.
Discontinuation[edit]
The BPC was last published in 1973. It was replaced by the British National Formulary (BNF), which is now the standard reference for prescribing in the UK.
See also[edit]
- Pharmaceutical Society of Great Britain
- British Pharmacopoeia
- British National Formulary
- United States Pharmacopeia
- Pharmacopoeia of India
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
